| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/10/2008 | US20080166767 Using immortalized cells comprising vector coding cytomegalo viral regulatory sequences to propagate immunoglobulins |
| 07/10/2008 | US20080166764 Expression vector comprising nucleic acid which encodes signal sequence and heterologous protein; for use in transformation and expression in escherichia |
| 07/10/2008 | US20080166763 Human toll homologues |
| 07/10/2008 | US20080166759 Nucleotide sequences coding chimeric immunoglobulin comprising salvage receptor binding epitope for use as reporter in immunodiagnostic and immunotherapeutics |
| 07/10/2008 | US20080166743 Trp8, a transient receptor potential channel expressed in taste receptor cells |
| 07/10/2008 | US20080166742 Method of Detecting or Monitoring a Malignant Plasma Cell Disease |
| 07/10/2008 | US20080166732 Gene transfer vector comprising polymerase for use as diagnostic tool in cancer detection |
| 07/10/2008 | US20080166731 Plant caffeic acid-3-O-methytransferase homologs |
| 07/10/2008 | US20080166724 VEGF-Modulated Genes and Methods Employing Them |
| 07/10/2008 | US20080166701 Pre-treating with cation exchanger, mixing specimen with antibody sensitization particle, and measuring agglutination; disposable |
| 07/10/2008 | US20080166698 Antibodies for cancer therapy and diagnosis |
| 07/10/2008 | US20080166469 Preparation of Canola Protein Isolate and Use in Aquacultre |
| 07/10/2008 | US20080166376 Nucleic acids, proteins and vectors containing a nucleotide sequence encoding a full-length or a truncated form of the 60kCRMP gene product of a strain of Chlamydia; vaccines |
| 07/10/2008 | US20080166375 Activation of Recombinant Diphtheria Toxin Fusion Proteins by Specific Proteases Highly Expressed on the Surface of Tumor Cells |
| 07/10/2008 | US20080166374 Formulating an anti-cancer vaccine comprising an agent that can stimulate an immune response against IL-13R alpha 2 outside of the subject, and administering the vaccine to the subject |
| 07/10/2008 | US20080166364 Conjugated to antibody; thrombospondin receptor targeting |
| 07/10/2008 | US20080166363 Improved targetting |
| 07/10/2008 | US20080166362 New effector conjugates, process for their production and their pharmaceutical use |
| 07/10/2008 | US20080166361 Monoclonal antibody conjugate for targeting 10-boron to tumor cells; boron neutron capture therapy |
| 07/10/2008 | US20080166360 Recombinant pollen protein for use in diagnosis, prevention and treatment of allergies |
| 07/10/2008 | US20080166356 Treating bone disorders resulting in increased trabecular bone formation, decreased osteoblast and osteocyte apoptosis and increased osteoprogenitor differentiation |
| 07/10/2008 | US20080166354 Using monoclonal antibody specific to inhibitor of protease or of a non-proteolytic matrix-degrading enzyme (IPNME) as therapeutic tool in treatment of cell proliferative disorders |
| 07/10/2008 | US20080166353 Using immunoglobulin specific to receptor for OX-2 membrane glycoprotein as diagnostic and therapeutic tool for treatment and prevention of asthma, infection, allergies, skin and cell proliferative disorders |
| 07/10/2008 | US20080166352 B7 related protein-1specific immunogobulin for use in treatment and prevention of asthma, skin, rheumatic and autoimmune disorders |
| 07/10/2008 | US20080166351 Kit comprising beacizumab and antitumor agents for use in treatment of metastatic colorectal cancer in a human |
| 07/10/2008 | US20080166350 Nucleotide sequences coding tumor associated antigens for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 07/10/2008 | US20080166347 Human antibodies specific for interleukin 15 (IL-15) |
| 07/10/2008 | US20080166346 Freeze dried monoclonal antibody specific for endothelial growth factor receptors for use treatment of cell proliferative disorders; enhanced storage stability |
| 07/10/2008 | US20080166345 Medicaments comprising gene recombinant antibody against ganglioside gd3 |
| 07/10/2008 | US20080166343 High affinity antibody antagonists of interleukin-13 receptor alpha 1 |
| 07/10/2008 | US20080166342 Major histocompatibility complex specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative, inflammatory, autoimmune, liver and kidney disorders |
| 07/10/2008 | US20080166341 Cripto blocking antibodies and uses thereof |
| 07/10/2008 | US20080166337 Nucleotide sequences coding tumor associated differentially-expressed gene-12 (TADG-12) protein (serine protease) for use as tool in tissue targeted cancer therapy |
| 07/10/2008 | US20080166336 CD137 agonists to treat patients with IgE-mediated conditions |
| 07/10/2008 | US20080166295 Administering an antibody that selectively binds to the extracellular region of human magic roundabout (MR); inhibiting angiogenesis |
| 07/10/2008 | US20080166294 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 07/10/2008 | CA2764852A1 Method of providing disease-specific binding molecules and targets |
| 07/10/2008 | CA2674239A1 Methods and vectors for generating asialylated immunoglobulins |
| 07/10/2008 | CA2674140A1 Method of providing disease-specific binding molecules and targets |
| 07/10/2008 | CA2673968A1 Use of heat-resistant biotin-binding protein, and solid support having the protein attached thereto |
| 07/10/2008 | CA2673870A1 Compositions and methods for the treatment of infections and tumors |
| 07/10/2008 | CA2673868A1 Neutralization of cd95 activity blocks invasion of glioblastoma cells in vivo |
| 07/10/2008 | CA2673668A1 Methods of selecting and producing modified toxins, conjugates containing modified toxins and uses thereof |
| 07/09/2008 | EP1942346A1 Multihued labels |
| 07/09/2008 | EP1942191A1 Nucleic acid construct containing full-length genome of human hepatitis C virus, recombinant full-length virus genome-replicating cells having the nucleic acid construct transferred thereinto and method of producing hepatitis C virus particle |
| 07/09/2008 | EP1942190A2 Immoglobulin fusion proteins having modified effector functions and uses thereof |
| 07/09/2008 | EP1942187A1 Cytokine protein family |
| 07/09/2008 | EP1942116A1 Monoclonal antibodies for selective immunological regulation of high-molecular intact laminin forms in bodily fluids |
| 07/09/2008 | EP1942114A2 Mammalian cytokines; related reagents and methods |
| 07/09/2008 | EP1941909A1 Preventives/remedies for cancer |
| 07/09/2008 | EP1941905A1 APO-2 Ligand-anti-her-2 antibody synergism |
| 07/09/2008 | EP1941904A2 Anti-TNF antibodies and methotrexate in the treatment of autoimmune diseases |
| 07/09/2008 | EP1941872A1 Use of TNF-alpha inhibitors for treating nerve root injury |
| 07/09/2008 | EP1941275A2 Method of identifying membrane lg specific antibodies and use thereof for targeting immunoglobulin-producing precursor cells |
| 07/09/2008 | EP1941039A2 Organic compounds |
| 07/09/2008 | EP1940881A2 Compositions comprising cross-species-specific antibodies and uses thereof |
| 07/09/2008 | EP1940880A2 Treating diabetes using inhibitors of il-1 |
| 07/09/2008 | EP1940879A1 Reagents and methods for the detection of transmissible spongiform encephalopathy |
| 07/09/2008 | EP1940878A1 Expression control using antibody expression optimisation sequences |
| 07/09/2008 | EP1940870A2 Conserved membrane activator of calcineurin (cmac), a novel therapeutic protein and target |
| 07/09/2008 | EP1940864A2 Method for generating anti-variable region monoclonal antibodies |
| 07/09/2008 | EP1940470A2 Antibody-drug conjugates and methods of use |
| 07/09/2008 | EP1940465A2 Novel use of il-1beta compounds |
| 07/09/2008 | EP1715890B1 Ctgf as target for the therapy of microalbuminuria in patients with diabetic nephropathy |
| 07/09/2008 | EP1535627B1 Recombinant bcg vaccine |
| 07/09/2008 | EP1523571B1 Sgk and nedd used as diagnostic and therapeutic targets |
| 07/09/2008 | EP1404362B1 Signal-1/signal-2 bifunctional peptide inhibitors |
| 07/09/2008 | EP1403281B1 Novel ligand and dna thereof |
| 07/09/2008 | EP1226177B1 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use |
| 07/09/2008 | EP1156820B1 Use of vascular endothelial growth factor-2 (vegf-2) |
| 07/09/2008 | EP0932674B1 A NOVEL MAMMALIAN GENE, bcl-w, BELONGS TO THE bcl-2 FAMILY OF APOPTOSIS-CONTROLLING GENES |
| 07/09/2008 | EP0832189B2 Process for controlling sialylation of proteins produced by mammalian cell culture |
| 07/09/2008 | EP0804584B2 Sequences of hepatitis c virus genotype 7 and their use as prophylactic, therapeutic and diagnostic agents |
| 07/09/2008 | EP0760851B1 Tumor necrosis factor receptor-associated factors |
| 07/09/2008 | EP0476130B1 Enterically transmitted non-a/non-b hepatitis viral agent and characteristic epitopes thereof |
| 07/09/2008 | CN101218353A Predicting treatment response in cancer subjects |
| 07/09/2008 | CN101218351A Anti-CD19 antibodies and uses in oncology |
| 07/09/2008 | CN101218257A GITR binding molecules and uses therefor |
| 07/09/2008 | CN101218256A Antibodies against cd38 for treatment of multiple myeloma |
| 07/09/2008 | CN101218255A Anti-GM-CSF antibodies and uses therefor |
| 07/09/2008 | CN101218254A Interleukin-17F antibodies and other IL-17F signaling antagonists and uses therefor |
| 07/09/2008 | CN101218253A Cardiovascular disease therapies |
| 07/09/2008 | CN101218252A Use of PANTON-VALENTINE leukocidin for treating and preventing staphylococcus infections |
| 07/09/2008 | CN101218251A 异二聚体蛋白结合组合物 Heterodimeric protein binding compositions |
| 07/09/2008 | CN101217978A Methods for treating osteoarthitis pain by administering a nerve growth factor antagonist and compositions containing the same |
| 07/09/2008 | CN101215332A CRIPTO blocking antibodies and uses thereof |
| 07/09/2008 | CN101215331A Method for preparing tomato A virus Zhejiang separator monoclonal antibody and use thereof |
| 07/09/2008 | CN101215323A Human AD7C-NTP antigen determinant polypeptide, antibody and application thereof in diagnosis kit |
| 07/09/2008 | CN101215322A Artificial antigen and antibody of furazolidone metabolite 3-amino-2-oxazolidone and preparation method thereof |
| 07/09/2008 | CN101214376A Cytotoxicity mediation of cells evidencing surface expression of CD63 |
| 07/09/2008 | CN101214372A Construction method of protein vaccine for in vivo inducing autoantibody aiming at TNF-alpha molecule |
| 07/09/2008 | CN100401068C Diagnosis of hepatocellular carcinoma |
| 07/09/2008 | CN100401064C Method for mapping and eliminating T-cell epitopes |
| 07/09/2008 | CN100400658C New type human death resist protein, its coded sequence and use |
| 07/09/2008 | CN100400657C Phosphokinase and the usage thereof |
| 07/09/2008 | CN100400547C Human monoclonal antibodies to prostate specific membrane antigen |
| 07/09/2008 | CN100400546C Cell surface molecule mediating cell adhesion and signal transmission |
| 07/08/2008 | US7396920 Tumour suppressor and uses thereof |
| 07/08/2008 | US7396917 Immunoglobulin for diagnosing and treating cancers and related disorders such as thrombocytopenia |
| 07/08/2008 | US7396916 Antibody to a polypeptide overexpressed in tumors |